These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12638448)

  • 21. [Dementia].
    Diehl RR
    Fortschr Neurol Psychiatr; 2003 Nov; 71(11):617-28. PubMed ID: 14608514
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
    Wilkinson D; Andersen HF
    Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Memantine].
    Molinuevo JL
    Neurologia; 2003 Jun; 18(5):255-61. PubMed ID: 12768511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial.
    Pomara N; Ott BR; Peskind E; Resnick EM
    Alzheimer Dis Assoc Disord; 2007; 21(1):60-4. PubMed ID: 17334274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease.
    Reisberg B; Doody R; Stöffler A; Schmitt F; Ferris S; Möbius HJ
    Arch Neurol; 2006 Jan; 63(1):49-54. PubMed ID: 16401736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Early treatment with anti-dementia drugs when possible. These signs reveal Alzheimer disease].
    MMW Fortschr Med; 2003 Jun; 145(23):60. PubMed ID: 12854234
    [No Abstract]   [Full Text] [Related]  

  • 28. Memantine (Namenda) for moderate to severe Alzheimer's disease.
    Ables AZ
    Am Fam Physician; 2004 Mar; 69(6):1491-2. PubMed ID: 15053415
    [No Abstract]   [Full Text] [Related]  

  • 29. Different conclusions about memantine.
    Lexchin J
    Can Fam Physician; 2007 Mar; 53(3):403-4; author reply 404. PubMed ID: 17872671
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
    Schölzel-Dorenbos CJ;
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
    Schifitto G; Navia BA; Yiannoutsos CT; Marra CM; Chang L; Ernst T; Jarvik JG; Miller EN; Singer EJ; Ellis RJ; Kolson DL; Simpson D; Nath A; Berger J; Shriver SL; Millar LL; Colquhoun D; Lenkinski R; Gonzalez RG; Lipton SA; ; ;
    AIDS; 2007 Sep; 21(14):1877-86. PubMed ID: 17721095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memantine: the next trend in academic performance enhancement?
    Ota KS; Godwin T
    J Am Osteopath Assoc; 2006 Jun; 106(6):358-9. PubMed ID: 16790543
    [No Abstract]   [Full Text] [Related]  

  • 33. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis.
    Gauthier S; Loft H; Cummings J
    Int J Geriatr Psychiatry; 2008 May; 23(5):537-45. PubMed ID: 18058838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memantine (Ebixa) in clinical practice - results of an observational study.
    Calabrese P; Essner U; Forstl H
    Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease.
    Rabins PV; Lyketsos CG
    Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739
    [No Abstract]   [Full Text] [Related]  

  • 36. Magnesium supplementation in the treatment of dementia patients.
    Ozturk S; Cillier AE
    Med Hypotheses; 2006; 67(5):1223-5. PubMed ID: 16790324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of memantine.
    Johnson JW; Kotermanski SE
    Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
    Wenk GL
    J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecule of the month. Memantine hydrochloride.
    Drug News Perspect; 2003; 16(1):55. PubMed ID: 12682671
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA approves memantine drug for treating AD.
    Am J Alzheimers Dis Other Demen; 2003; 18(6):329-30. PubMed ID: 14682078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.